ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651694 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651694; 2) Community: the network communities that were significantly associated with the response to NSC 651694; 3) Molecule: the relationships between components within communities and NSC 651694; 4) MDR: the compounds that were significantly associated with the NSC 651694.

NSC Compound Enrichment Correlation
NSC 720719 Null 0.00134664791567076 0.031186812
NSC 87500 Solacongestidine 0.00134664791567076 0.34085542
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0013655184802855 0.14337931
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0013655184802855 0.089469586
NSC 753598 Null 0.0013655184802855 0.23347278
NSC 619837 Null 0.00136551848028552 0.3867976
NSC 4290 Null 0.00140570135773563 0.092175374
NSC 4857 Carbamic acid, diethyldithio-, sodium salt (8CI) 0.00140570135773563 0.39870799
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.00140570135773563 0.46905556
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.00140570135773563 0.43816457
Total:91  Current:5    [First] [Prev] [Next] [Last]